As the cornerstone of public health, ensuring vaccine safety through post-marketing monitoring is critical. Regulators seek to evaluate risk–benefit in real world settings and monitor for rare outcomes. The PHARMO Institute, part of Lumanity, conducts collaborative post-licensure studies on vaccine benefits, safety, and coverage. Read more in our factsheet.

We invite you to put our data to the test. E-mail us at contact@lumanity.com to discuss your research needs.

Access our factsheet

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.